Overview:

Amniotic membrane is quite important for body to initiate healing. It is a combination of tissues and cells, which acts as a foundation for re-growth of soft tissues. Amniotic membrane has wide-scale utility in eye surgery that acts like a biological bandage. The process heals or replaces eye tissues that are damaged. The global amniotic membrane market is all set to garner USD 1,210.9 million during the forecast period (2018-2023) with a CAGR of 12.16%. Market Research Future (MRFR) declared the possibility for the amniotic membrane market exceeding the predicted valuation is quite high.

The amniotic membrane market share can rely on substantial surge in amniotic membrane-based transplantations globally. Also, health-related awareness is on the rise, which is expected to spur the global market growth. 

Competitive Landscape: 

Several companies are experiencing substantial growth due to the surge in the ingress level of the amniotic membrane market. These companies have been profiled by MRFR in their report on the same market for a better understanding of strategic moves and trends that can inspire market change. These companies are Applied Biologics (US), Alliqua BioMedical, Inc. (US), Integra LifeSciences (US), Skye Biologics Inc. (California), MiMedx (US), Amniox Medical, Inc. (Florida), Katena Products, Inc. (US), Human Regenerative Technologies, LLC (US), Amnio Technology, LLC (US), and Osiris Therapeutics, Inc. (US).

Segmentation:

MRFR’s analysis of the amniotic membrane market is based on an extensive segmentation that includes type, application, and end-user. This segmentation gets solid backup from the value-wise and volume-wise analysis of the market. 

Based on the type, the global amniotic membrane market can be segmented into cryopreserved and lyophilized. traditional therapy was followed by placement of a dehydrated amniotic membrane allograft and the healing time course was documented with charted measurements. The cryopreservation amniotic membrane segment has better potential to lead the market with an impressive CAGR to reach USD 1,090.08million by the end of 2023. This is expected to get driven by the rising number of ocular surgeries. The lyophilized amniotic membrane segment, on the other hand, can project the highest CAGR of 14.18% during the forecast period. This growth is expected to rely mostly on rising number of surgeries, reconstruction procedures, cosmetic surgeries, and venous & pressure leg ulcers.  

Regional Analysis:

MRFR in their region-specific take on the global amniotic membrane market includes namely, the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). This region-specific segmentation allows a closer look at the growth pockets that unravels later market possibilities. 

The Americas had the largest market share and it covered around 37.6% in 2017 and at present, it is slated to score an impressive CAGR of 13.28%during the forecast period. The APAC market is geared up to record the fastest CAGR during the forecast period. It has a huge market potential and can achieve 13.60% CAGR during the forecast period.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.